chemistry4 papersavg year 2026weak evidence

Current anticancer strategies have limitations

Research gap analysis derived from 4 chemistry papers in our local library.

The gap

Current anticancer strategies have limitations such as multidrug resistance, bioavailability challenges, and treatment complexity. There is a need for novel anticancer agents that can overcome these limitations.

Evidence profile

Sourced from the stated research gap of the source papers, classified as general, drawn from work published between 2024 and 2026, spanning 4 journals. Those papers have been cited 6 times in total.

Research trend

Established — well-defined area with open sub-problems.

Supporting evidence — 4 representative gaps

  • Molecular docking, ADMET, synthesis and evaluation of new indomethacin hydrazide derivatives as antibacterial agents (2024) · Pharmacia · cited 6× · doi

    The prevalence of drug-resistant bacterial pathogen strains reduces current therapies' efficacy and increases the risk of developing new bacterial infections. There is a need for novel, low-toxic medications that are both effective and have unique mechanisms of action.

    generalstated research gap
    Keywords: prevalence drug-resistant bacterial pathogen strains reduces current therapies
  • Novel C3/C28-bis-1,2,4-Triazolyl-sulfanylacetate-betulin Derivatives: Synthesis and Evaluation of Anticancer Potential (2026) · International Journal of Molecular Sciences · doi

    Current anticancer strategies have limitations such as multidrug resistance, bioavailability challenges, and treatment complexity. There is a need for novel anticancer agents that can overcome these limitations.

    generalstated research gap
    Keywords: current anticancer strategies have limitations multidrug resistance bioavailability
  • IN SILICO MOLECULAR DOCKING STUDIES OF NOVEL 1,3,4-OXADIAZOLE DERIVATIVES AS POTENT MULTI-TARGET AGENTS: EXPLORING ANTIMICROBIAL, ANTICANCER, ANTIFUNGAL, AND ANTI-INFLAMMATORY POTENTIAL (2026) · European Journal Pharmaceutical and Medical Research · doi

    The rising prevalence of multidrug-resistant pathogens and complex diseases necessitates the development of multi-target therapeutic agents. The lack of effective therapeutic agents for the treatment of cancer, bacterial/fungal infections, and inflammation highlights the need for novel approaches.

    generalstated research gapevidence 5/5
    Keywords: rising prevalence multidrug-resistant pathogens complex diseases necessitates development
  • Biocompatible pluronic F127 coated TiO₂/ZnTiO₃ hybrid nanomaterial: Structural insights and bioactivity against bacteria and blood cancer cells (2026) · Journal of Sol-Gel Science and Technology · doi

    There is a need for effective multifunctional therapeutic agents for the treatment of blood cancers and bacterial infections. Conventional treatment strategies have limitations such as drug resistance and systemic toxicity.

    generalstated research gapevidence 5/5
    Keywords: there need effective multifunctional therapeutic agents treatment blood

Questions about this gap

Current anticancer strategies have limitations such as multidrug resistance, bioavailability challenges, and treatment complexity. There is a need for novel anticancer agents that… This is supported by 4 representative gap statements extracted from 4 papers, rated weak evidence.

Explore this gap further

Run this gap as a query across open scholarly engines for the latest related literature.

Working on this gap? Review it with us.

Science AI Journal reviews manuscripts in one pass with 8 specialised AI agents calibrated on 69,000+ real peer reviews.

Related gaps in Chemistry

Command palette

Jump anywhere, run any action.